Allogeneic hematopoietic stem cell transplantation for refractory mycosis fungoides (MF) and Sezary syndrome (SS)
- PMID: 28466385
- DOI: 10.1007/s12185-017-2245-x
Allogeneic hematopoietic stem cell transplantation for refractory mycosis fungoides (MF) and Sezary syndrome (SS)
Abstract
Cutaneous T cell lymphoma is a heterogeneous group of lymphoproliferative disorders with different clinical behavior and prognosis in which malignant T cells accumulate in the skin. In the relapsed/refractory stage, treatment strategy varies depending on clinical perspective. We retrospectively evaluated advanced stage relapse or refractory mycosis fungoides and Sezary syndrome patients who underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT) at our hospital. The overall response rate was 25%, while the disease progressed and relapsed after transplant in 38% of patients. Allo-HSCT may be a reasonable treatment option in the relapsed/refractory stage.
Keywords: Allogeneic hematopoietic stem cell transplantation; Mycosis fungoides; Sezary syndrome.
Similar articles
-
Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning for mycosis fungoides and Sezary syndrome.Hematol Oncol. 2016 Mar;34(1):9-16. doi: 10.1002/hon.2162. Epub 2014 Oct 14. Hematol Oncol. 2016. PMID: 25312300
-
Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.Bone Marrow Transplant. 2021 Jun;56(6):1391-1401. doi: 10.1038/s41409-020-01197-3. Epub 2021 Jan 8. Bone Marrow Transplant. 2021. PMID: 33420392
-
Transformation of Mycosis Fungoides/Sezary Syndrome: Clinical Characteristics and Prognosis.Turk J Haematol. 2018 Mar 1;35(1):35-41. doi: 10.4274/tjh.2016.0502. Epub 2017 May 23. Turk J Haematol. 2018. PMID: 28533196 Free PMC article.
-
Allogeneic hematopoietic stem cell transplantation in advanced stage mycosis fungoides and Sézary syndrome: a concise review.Chin Clin Oncol. 2019 Feb;8(1):12. doi: 10.21037/cco.2018.10.03. Epub 2018 Oct 19. Chin Clin Oncol. 2019. PMID: 30525754 Review.
-
Allogeneic stem cell transplant for treatment of mycosis fungoides and Sezary syndrome: a systematic review and meta-analysis.Bone Marrow Transplant. 2024 Jan;59(1):41-51. doi: 10.1038/s41409-023-02122-0. Epub 2023 Oct 18. Bone Marrow Transplant. 2024. PMID: 37853164
Cited by
-
BET inhibition in advanced cutaneous T cell lymphoma is synergistically potentiated by BCL2 inhibition or HDAC inhibition.Oncotarget. 2018 Jun 26;9(49):29193-29207. doi: 10.18632/oncotarget.25670. eCollection 2018 Jun 26. Oncotarget. 2018. PMID: 30018745 Free PMC article.
-
Clinical outcomes and prognostic factors in patients with mycosis fungoides who underwent radiation therapy in a single institution.Radiat Oncol J. 2018 Jun;36(2):153-162. doi: 10.3857/roj.2017.00542. Epub 2018 Jun 29. Radiat Oncol J. 2018. PMID: 29983036 Free PMC article.
-
Long-term complete remission of early hematological relapse after discontinuation of immunosuppressants following allogeneic transplantation for Sezary syndrome.Hematol Rep. 2018 Sep 5;10(3):7497. doi: 10.4081/hr.2018.7497. eCollection 2018 Sep 5. Hematol Rep. 2018. PMID: 30283619 Free PMC article.
-
Mycosis Fungoides: Analysis of Ophthalmologic Findings in a Series of Cases.Case Rep Dermatol Med. 2019 Jan 20;2019:2380598. doi: 10.1155/2019/2380598. eCollection 2019. Case Rep Dermatol Med. 2019. PMID: 30805223 Free PMC article.
-
Leukaemic variants of cutaneous T-cell lymphoma: Erythrodermic mycosis fungoides and Sézary syndrome.Best Pract Res Clin Haematol. 2019 Sep;32(3):239-252. doi: 10.1016/j.beha.2019.06.004. Epub 2019 Jun 6. Best Pract Res Clin Haematol. 2019. PMID: 31585624 Free PMC article. Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical